Precision Psychobiotics for Gut–Brain Axis Health: Advancing the Discovery Pipelines to Deliver Mechanistic Pathways and Proven Health Efficacy
ABSTRACT Advancing microbiome–gut–brain axis science requires systematic, rational and translational approaches to bridge the critical knowledge gaps currently preventing full exploitation of the gut microbiome as a tractable therapeutic target for gastrointestinal, mental and brain health. Current...
Saved in:
Main Authors: | Rebecca F. Slykerman, Naomi Davies, Klara Vlckova, Kenneth J. O'Riordan, Shalome A. Bassett, James Dekker, Harriët Schellekens, Niall P. Hyland, Gerard Clarke, Elaine Patterson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Microbial Biotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1111/1751-7915.70079 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psychobiotics, Novel Therapeutic Agents for the Psychiatric Disorders
by: Praveen Reddy P., et al.
Published: (2025-02-01) -
Application of psychobiotics in clinical treatment of mental disorders: Neurodevelopmental disorders, neurodegenerative diseases, depression and anxiety
by: Jingwei Cui, et al.
Published: (2025-01-01) -
Conserved pattern-based classification of human odorant receptor multigene family
by: Sang Eun Ryu, et al.
Published: (2024-11-01) -
Muscarinic acetylcholine type 1 receptor antagonism activates TRPM3 to augment mitochondrial function and drive axonal repair in adult sensory neurons
by: Sanjana Chauhan, et al.
Published: (2025-02-01) -
Psychobiotic effects of probiotics and prebiotics
by: V. T. Ivashkin, et al.
Published: (2018-08-01)